A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Biochemistry

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1046/J.1432-1327.2000.01174.XPMID 10712609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (β2-glycoprotein I) to anionic phospholipids

  2004cited by this paper
• Genetic variation in the apolipoprotein H (β2-glycoprotein I) gene affects plasma apolipoprotein H concentrations

  1999cited by this paper
• Genetic variation in apolipoprotein H (β2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus

  1999cited by this paper
• Mutation of Tryptophan Residues in Lipoprotein Lipase

  1997cited by this paper
• Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding.

  1997cited by this paper
• Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism.

  1997cited by this paper
• Phospholipid Binding Plasma Proteins Required for Antiphospholipid Antibody Detection—An Overview

  1997cited by this paper
• Molecular basis of the apolipoprotein H (β2-glycoprotein I) protein polymorphism

  1997cited by this paper
• Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity.

  1996cited by this paper
• Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.

  1995cited by this paper
• Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome.

  1995cited by this paper
• Heterogeneity of the apolipoprotein H * 3 allele and its role in affecting the binding of apolipoprotein H (β2-glycoprotein I) to anionic phospholipids

  1995cited by this paper
• The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.

  1994cited by this paper
• IgG2 subclass restriction of anti‐β2 glycoprotein 1 antibodies in autoimmune patients

  1994cited by this paper
• Characterization and Acute-Phase Modulation of Canine Apolipoprotein H (β2-Glycoprotein 1)

  1993cited by this paper
• Human beta 2-glycoprotein I: molecular analysis of DNA and amino acid polymorphism.

  1993cited by this paper
• Characterization and acute phase modulation of canine apolipoprotein H (beta 2-glycoprotein I).

  1993cited by this paper
• Changes in β2-Glycoprotein I Antigenicity Induced by Phospholipid Binding

  1993cited by this paper
• Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.

  1993cited by this paper
• Activity, disulphate mapping and structural modelling of the fifth domain of human β2‐glycoprotein I

  1992cited by this paper
• Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome.

  1992cited by this paper
• Transfection Using DEAE‐Dextran

  1992cited by this paper
• Antiphospholipid antibodies require beta 2-glycoprotein I (apolipoprotein H) as cofactor.

  1992cited by this paper
• Activity, disulphide mapping and structural modelling of the fifth domain of human beta 2-glycoprotein I.

  1992cited by this paper
• Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains.

  1991cited by this paper
• Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals.

  1991cited by this paper
• Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I.

  1991cited by this paper
• Nucleotide sequence and expression of the human gene encoding apolipoprotein H (β2-glycoprotein I)

  1991cited by this paper
• Nucleotide sequence and expression of the human gene encoding apolipoprotein H (beta 2-glycoprotein I).

  1991cited by this paper
• Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA.

  1991cited by this paper
• Molecular cloning and mammalian expression of human β2‐glycoprotein I cDNA

  1991cited by this paper
• Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

  1990cited by this paper
• Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.

  1990cited by this paper
• Initiation of translation at CUG, GUG, and ACG codons in mammalian cells.

  1990cited by this paper
• Structure of transglutaminases.

  1990cited by this paper
• The primary structure of rat 2 -glycoprotein I

  1989cited by this paper
• The primary structure of rat beta 2-glycoprotein I.

  1989cited by this paper
• Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I).

  1988cited by this paper
• The superfamily of C3b/C4b-binding proteins.

  1987cited by this paper
• Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins

  1987cited by this paper
• Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-I

  1986cited by this paper
• Structural features of the proteins participating in blood coagulation and fibrinolysis.

  1986cited by this paper
• Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I.

  1986cited by this paper
• Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins.

  1986cited by this paper
• beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway.

  1985cited by this paper
• A novel strategy for constructing clustered point mutations.

  1985cited by this paper
• Complete amino acid sequence of human plasma beta 2-glycoprotein I.

  1984cited by this paper
• High efficiency gene transfer into mammalian cells.

  1984cited by this paper
• A rapid boiling method for the preparation of bacterial plasmids.

  1981cited by this paper
• Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I).

  1980cited by this paper
• Binding of β2-glycoprotein I to platelets: Effect of adenylate cyclase activity

  1980cited by this paper
• Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity.

  1980cited by this paper
• On the population genetics of beta2-glycoprotein I.

  1979cited by this paper
• On the Population Genetics of β2-Glycoprotein I

  1979cited by this paper
• The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions.

  1979cited by this paper
• Binding of beta 2-glycoprotein-I to intralipid: determination of the dissociation constant.

  1979cited by this paper
• The relation of sex, smoking status, birth rank, and parental age to β2-glycoprotein I levels and phenotypes in a sample of Australian Caucasian adults

  1978cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Investigations on the genetics and population genetics of the beta 2-glycoprotein I polymorphism.

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• [Genetic studies on the deficiency of beta 2-glycoprotein I of human serum].

  1968cited by this paper

• Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome

  2025cites this paper
• Development of betabodies: The next generation of phosphatidylserine targeting agents

  2024influential citation
• Atomistic Characterization of β2-Glycoprotein I Domain V Interaction with Anionic Membranes.

  2024cites this paper
• Atomistic Characterization of Beta-2-Glycoprotein I Domain V Interaction with Anionic Membranes

  2024cites this paper
• Effects of apolipoprotein H downregulation on lipid metabolism, fatty liver disease, and gut microbiota dysbiosis

  2023cites this paper
• Apolipoprotein H induces sex-specific steatohepatitis and gut dysbiosis during chronic hepatitis B infection

  2023cites this paper
• Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice

  2022cites this paper
• Beta2 glycoprotein I-derived therapeutic peptides induce sFlt-1 secretion to reduce melanoma vascularity and growth.

  2020cites this paper
• Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops

  2017cites this paper
• Synthesis of Phospholipid-Protein Conjugates as New Antigens for Autoimmune Antibodies

  2015influential citation
• Association of the Trp316Ser variant (rs1801690) near the apolipoprotein H (β2-glycoprotein-I) gene and serum lipid levels.

  2015cites this paper
• Charged Particles can Mediate Attraction Between Equally Charged Membranes—Theoretical Study

  2014cites this paper
• Influence of ionic strength and beta2-glycoprotein I concentration on agglutination of like-charged phospholipid membranes.

  2013cites this paper
• Identification of the binding site for fondaparinux on Beta2-glycoprotein I.

  2013cites this paper
• β₂-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator.

  2011cites this paper
• Apolipoprotein H, an Acute Phase Protein, a Performing Tool for Ultra-Sensitive Detection and Isolation of Microorganisms from Different Origins

  2011cites this paper
• Recombinant domain V of β2-glycoprotein I inhibits the formation of a 7-ketocholesteryl-9-carboxynonanoate and β2-glycoprotein I complex.

  2011cites this paper
• Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy

  2010cites this paper
• Mode of interaction between beta2GPI and lipoprotein receptors suggests mutually exclusive binding of beta2GPI to the receptors and anionic phospholipids.

  2010cites this paper
• A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome

  2010cites this paper
• The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.

  2010cites this paper
• Functional and genetic characterization of the promoter region of apolipoprotein H (β2‐glycoprotein I)

  2010cites this paper
• Structural insights into recognition of β2‐glycoprotein I by the lipoprotein receptors

  2009cites this paper
• [Val247Leu polymorphism of beta2 glycoprotein 1 gene may justify the genesis of anti beta2GP1 antibodies and antiphospholipid syndrome in multibacillary leprosy].

  2009cites this paper
• Polimorfismo Val247Leu do gene β2-glicoproteína 1 pode justificar a gênese de anticorpos antiβ2GP1 e síndrome do anticorpo antifosfolípide na hanseníase multibacilar

  2009cites this paper
• FUNCTIONAL CHARACTERIZATION OF APOLIPOPROTEIN H POLYMORPHISMS AND THEIR RELATION TO SYSTEMIC LUPUS ERYTHEMATOSUS

  2009cites this paper
• Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H).

  2008cites this paper
• Chapter 8 Interactions of Phospholipid Binding Proteins with Negatively Charged Membranes: β2‐Glycoprotein I as a Model Mechanism

  2008cites this paper
• Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies.

  2008cites this paper
• The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.

  2007cites this paper
• Development of Automated Assays for Anticardiolipin Antibodies Determination: Addressing Antigen and Standardization Issues

  2007cites this paper
• ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN APOLIPOPROTEIN H (APOH) WITH SYSTEMIC LUPUS ERYTHEMATOSUS

  2007cites this paper
• Investigating the molecular targets of antiphospholipid antibodies

  2007cites this paper
• Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9.

  2006cites this paper
• Plasma Protein β-2-Glycoprotein 1 Mediates Interaction between the Anti-tumor Monoclonal Antibody 3G4 and Anionic Phospholipids on Endothelial Cells*

  2006cites this paper
• Antiphospholipid syndrome: characteristics and obstetrical management.

  2005cites this paper
• IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis.

  2005cites this paper
• Oxidation and biotinylation of beta 2 glycoprotein I glycan chains induce an increase in its affinity for anionic phospholipids similar to that obtained by the addition of anti-beta 2 glycoprotein I or anti-cardiolipin antibodies.

  2005cites this paper
• Domain V of β2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved at Lys317-Thr318*

  2005cites this paper
• ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN THE PROMOTER OF APOLIPOPROTEIN H WITH SYSTEMIC LUPUS ERYTHEMATOSUS

  2005cites this paper
• beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome.

  2004cites this paper
• Single Nucleotide Polymorphisms in the Coding Region of the Apolipoprotein H (β2‐Glycoprotein I) Gene and their Correlation with the Protein Polymorphism, Anti‐β2Glycoprotein I Antibodies and Cardiolipin Binding: Description of Novel Haplotypes and Their Evolution

  2004cites this paper
• The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin.

  2004cites this paper
• Pathophysiology of antiphospholipid antibodies.

  2004cites this paper
• Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′*

  2003cites this paper
• A simple method to discriminate between β2‐glycoprotein I‐ and prothrombin‐dependent lupus anticoagulants

  2003cites this paper
• A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I.

  2003cites this paper
• Studies on specific interaction of beta-2-glycoprotein I with HBsAg.

  2003cites this paper
• Phase separation of phospholipid monolayers induced by membrane penetration of human apolipoprotein H

  2002cites this paper
• Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids.

  2002cites this paper
• Human apolipoprotein H may have various orientations when attached to lipid layer.

  2002cites this paper
• Heparin Inhibits the Binding of β2-glycoprotein I to Phospholipids and Promotes the Plasmin-mediated Inactivation of This Blood Protein

  2002cites this paper
• β2-glycoprotein-I and Anti-β2-glycoprotein-I Antibodies1

  2002cites this paper
• Chimpanzee apolipoprotein H (β2-glycoprotein I): report on the gene structure, a common polymorphism, and a high prevalence of antiphospholipid antibodies

  2001cites this paper
• Probing the interface between membrane proteins and membrane lipids by X-ray crystallography.

  2001cites this paper
• Antiphospholipid antibodies and the coagulation cascade.

  2001cites this paper
• Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands.

  2001cites this paper
• Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes.

  2001cites this paper
• Dimers of β2-Glycoprotein I Mimic thein Vitro Effects of β2-Glycoprotein I-Anti-β2-glycoprotein I Antibody Complexes*

  2001cites this paper
• Structure-function studies on beta 2-glycoprotein I.

  2000cites this paper
• StructureFunction Studies on 2-glycoprotein I

  2000cites this paper
• Lupus anticoagulant in cardiovascular diseases: the role of beta2-glycoprotein I.

  2000cites this paper